93 7456 (Glipizide and Metformin Hydrochloride 2.5 mg / 500 mg)
Pill with imprint 93 7456 is White, Elliptical / Oval and has been identified as Glipizide and Metformin Hydrochloride 2.5 mg / 500 mg. It is supplied by Teva Pharmaceuticals USA.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7456
Glipizide and Metformin Hydrochloride
- Imprint
- 93 7456
- Strength
- 2.5 mg / 500 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 3350,
polyvinyl alcohol,
povidone k30,
povidone k90,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7456 | Teva Pharmaceuticals USA, Inc. |
| 42291-0305 | AvKare, Inc. |
More about glipizide / metformin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: antidiabetic combinations
Patient resources
- Other brands
- Metaglip
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.